What is the latest update in the healthcare AI market?

The healthcare AI market closed Q4 2025 with over $650 million in funding across 10 deals, nearly quadrupling the activity from the same quarter last year.

GE HealthCare made the biggest move of the quarter by acquiring Intelerad for $2.3 billion, signaling that large players are now aggressively consolidating control over imaging workflows.

We constantly update this blog post with the latest developments, so bookmark it and check back regularly.

And if you want to better understand this new industry, you can download our pitch covering the healthcare AI market.

Summary table of the most important updates in the healthcare AI market

We define the healthcare AI market as AI software and models used by healthcare providers, payers, life sciences companies, medtech firms, and public health bodies to improve clinical care, operations, and research.

We include clinical decision support, diagnostic and monitoring tools, hospital and clinic workflow and revenue cycle automation, payer analytics and claims tools, as well as AI used in pharma and biotech R&D, clinical trials, and connected medical devices.

We exclude general-purpose AI infrastructure, pure consumer wellness and fitness apps, and horizontal enterprise tools that are not purpose-built or primarily sold for healthcare use.

You can also get all the latest market news for the month here.

Piece of news	Category	Date	Source
GE HealthCare buys Intelerad for $2.3B to control imaging workflow and AI distribution	M&A	Nov 20, 2025	GE HealthCare
OpenEvidence raises $200M Series C at $6B valuation for AI-powered doctor search engine	Fundraisings	Oct 20, 2025	TechCrunch
Lila Sciences closes $350M Series A to build AI and robotic science factories	Fundraisings	Oct 15, 2025	Lila Sciences
Mosaic Clinical Technologies acquires Cognita to deploy radiology vision-language models	M&A	Nov 17, 2025	Mosaic Clinical
Hippocratic AI raises $126M Series C at $3.5B valuation to scale patient-facing AI agents	Fundraisings	Nov 3, 2025	Hippocratic AI
MedEvolve acquired by Emergence to expand AI-driven revenue cycle automation	M&A	Nov 11, 2025	Business Wire
EU delays major high-risk AI obligations, shifting healthcare AI compliance timelines	Regulations & Policies	Nov 19, 2025	Politico
CMS launches WISeR program to speed reviews of AI-powered prior authorization tools	Regulations & Policies	Oct 16, 2025	CMS
Microsoft Ignite 2025 spotlights agentic AI for healthcare operations and imaging	Product launches	Nov 18, 2025	Microsoft
Microsoft publishes Copilot and agentic AI adoption playbook for healthcare buyers	Product launches	Dec 2, 2025	Microsoft Tech Community
Heidi raises $65M Series B to scale AI clinical documentation globally	Fundraisings	Oct 6, 2025	Heidi Health
Adtalem and Google Cloud launch AI credential program for healthcare professionals	Partnerships	Oct 15, 2025	Reuters

How is the healthcare AI market doing now?

How do we define the healthcare AI market?

We define the healthcare AI market as AI software and models used by healthcare providers, payers, life sciences companies, medtech firms, and public health bodies to improve clinical care, operations, and research.

We include clinical decision support, diagnostic and monitoring tools, hospital and clinic workflow and revenue cycle automation, payer analytics and claims tools, as well as AI used in pharma and biotech R&D, clinical trials, and connected medical devices.

We exclude general-purpose AI infrastructure, pure consumer wellness and fitness apps, and horizontal enterprise tools that are not purpose-built or primarily sold for healthcare use.

This is also the definition we use in our report covering the healthcare AI market.

How big is the healthcare AI market in 2026?

We estimate the healthcare AI market is worth approximately $29 billion in 2026, based on our analysis of multiple research sources and bottom-up calculations.

This is not a random guess, if you want to know how we have come up with this estimate, you can read our healthcare AI market size analysis here.

For context, the healthcare AI market is now roughly the same size as the global cybersecurity software market (around $30 billion) and the customer relationship management software market (around $32 billion).

The healthcare AI market is still early-stage with a maturity score of 35/100, but it is highly competitive with eight unicorns and highly fragmented with over 1,000 FDA-authorized AI devices from hundreds of different companies.

How fast will the healthcare AI market grow in the future?

The healthcare AI market is expected to grow at approximately 37% annually through 2030, which is one of the fastest growth rates among enterprise software categories.

At this pace, the healthcare AI market should reach around $165 billion by 2030 and approximately $580 billion by 2036, representing a 20x increase over ten years.

For comparison, cloud computing grew at about 25% annually and cybersecurity at 12% during similar periods, so healthcare AI is outpacing both of these well-established tech categories.

What does current funding activity look like in the healthcare AI market?

Our team, who continually updates our healthcare AI market pitch deck, is keeping a close eye on the market and tracking key signals.

One of those signals is fundraising activity across startups. Each month, we refresh this page with a list of startups of the healthcare AI market that have raised funding, and we also publish a quarterly analysis here.

Is funding momentum accelerating or cooling in the healthcare AI market these days?

Healthcare AI funding in Q4 2025 reached $653 million across 10 deals, which is up 11% from Q3 2025 ($587 million) and shows steady momentum rather than a dramatic spike.

Compared to Q4 2024, which saw just $132 million across 4 deals, Q4 2025 funding is up nearly 400%, showing how much the healthcare AI market has accelerated in just one year.

The average deal size in Q4 2025 was $65 million, which is lower than Q2 2025's $186 million average but higher than Q4 2024's $33 million average. Q4 2025 had the most deals of any quarter (10), showing that capital is flowing to more companies rather than concentrating in just a few mega-rounds.

Which categories and business models are attracting capital in the healthcare AI market?

These categories and business models of the healthcare AI market are receiving important fundraising currently:

• Clinical documentation and AI scribes attracted four deals in Q4 2025 alone, including Heidi Health's $65 million and Noteless's $3.8 million, confirming automated note-taking is a must-have.
• Drug discovery and life sciences AI saw Chai Discovery raise $130 million to scale its biology foundation models for molecule design.
• Clinical decision support continued strong with OpenEvidence's $200 million Series C at a $6 billion valuation for its AI-powered medical search engine.
• Patient-facing AI agents received major backing through Hippocratic AI's $126 million Series C at a $3.5 billion valuation.
• Clinical trials infrastructure attracted Paradigm Health's $78 million Series B to make trials easier to access and run.

The pattern is clear: investors are betting on healthcare AI tools that can demonstrate fast ROI through time savings (documentation, trials) or that sit at critical decision points (clinical search, patient engagement).

Who's writing the most checks in the healthcare AI market?

These investors are being very active when it comes to fundraising in the healthcare AI market:

• Andreessen Horowitz was the most active investor with four deals across provider operations, patient engagement, claims automation, and care navigation categories.
• Thrive Capital participated in three major deals including OpenEvidence, Isomorphic Labs, and Chai Discovery, showing strong conviction in both clinical AI and drug discovery.
• Sequoia Capital backed OpenEvidence across multiple rounds (Series A, B, and C), demonstrating deep belief in AI-powered clinical decision support.
• Kleiner Perkins invested in Hippocratic AI, OpenEvidence, and Ambience Healthcare, focusing on clinical-facing AI tools that directly help physicians.
• GV (Google Ventures) led OpenEvidence's $200 million Series C and also backed Isomorphic Labs, positioning Google's venture arm as a major healthcare AI backer.

The top healthcare AI investors are placing concentrated bets, often returning to the same companies across multiple rounds rather than spreading capital thinly across many startups.

Any big acquisitions or IPOs in the last three months in the healthcare AI market?

These are the big acquisitions and IPOs that happened recently in the healthcare AI market:

• GE HealthCare agreed to acquire Intelerad for $2.3 billion in cash, giving GE control over imaging software distribution and the ability to accelerate AI adoption across its installed base.
• Mosaic Clinical Technologies (Radiology Partners' AI division) acquired Cognita Imaging to bring vision-language AI models in-house and address radiologist shortages with AI-assisted interpretation.
• MedEvolve was acquired by Emergence (backed by The Pritzker Organization) to expand AI-driven revenue cycle automation and reduce administrative waste in healthcare billing.

All three acquisitions show the same pattern: established players are buying AI capabilities to integrate into their existing distribution channels rather than building from scratch.

How are companies in the healthcare AI market performing overall?

We are watching this market everyday, because we need to constantly update our pitch deck. Here is a couple of things we have noticed.

Are there any standout success metrics or financial results in the healthcare AI market?

Yes, several healthcare AI companies reported strong performance signals in Q4 2025:

• Hippocratic AI reached a $3.5 billion valuation at its Series C round, making it one of the most valuable patient-facing AI agent companies in healthcare.
• OpenEvidence hit a $6 billion valuation with its Series C, becoming one of the highest-valued clinical decision support AI companies in the healthcare AI market.
• Lila Sciences closed $350 million in Series A funding with total capital raised reaching $550 million, signaling major investor confidence in AI-native life science R&D platforms.

These valuation jumps show that healthcare AI companies with clear product-market fit can command premium valuations comparable to leading enterprise software companies.

Have there been any major partnerships in the healthcare AI market?

Yes, there was one notable partnership announced in Q4 2025:

• Adtalem Global Education and Google Cloud launched an AI credential program designed to train healthcare students and professionals on practical AI use and ethics, addressing the adoption bottleneck of having trained users.

This partnership recognizes that healthcare AI adoption often stalls due to human factors rather than technical limitations, so training programs can unlock faster real-world deployment.

Have there been any notable technology or infrastructure breakthroughs in the healthcare AI market?

Yes, Microsoft made significant announcements about healthcare AI infrastructure in Q4 2025:

• Microsoft used Ignite 2025 to position "agentic AI" as practical tooling for healthcare teams, emphasizing security, scale, and building blocks for developers working on healthcare operations and imaging solutions.
• Microsoft's healthcare team published a deeper adoption playbook showing where Copilot and agentic AI fit into enterprise healthcare workflows, moving from concept to repeatable deployment story.

When a major cloud provider like Microsoft pushes a healthcare-specific AI story with clear enterprise guidance, it typically speeds up procurement cycles and buyer comfort across the industry.

Have any companies restructured or shifted pricing or business model in the healthcare AI market?

No, there hasn't been any major restructuring, pricing changes, or business model shifts announced during Q4 2025 in the healthcare AI market.

Are there any other notable wins or successes in the healthcare AI market?

No, there hasn't been any impressive win worth talking about beyond the fundraising, M&A, and partnership activities already covered during Q4 2025 in the healthcare AI market.

What is the overall sentiment in the healthcare AI market right now?

Are there any notable recent opinion pieces, thought leadership about the healthcare AI market?

No, we don't think there has been any notable opinion pieces worth mentioning here during Q4 2025 in the healthcare AI market based on our tracked news sources.

Are there any interesting and recent market research reports about the healthcare AI market?

Unfortunately, no, it seems like there hasn't been any notable or interesting market research published during Q4 2025 in the healthcare AI market that appeared in our tracked sources.

Have there been any regulatory changes, policy updates, or new compliance requirements in the healthcare AI market?

Yes, there were two significant regulatory developments in Q4 2025:

• EU institutions moved to delay parts of the AI Act timeline, including key dates for "high-risk" AI systems that often include healthcare applications. This gives healthcare AI vendors more time to prepare for compliance.
• CMS launched WISeR to improve and accelerate reviews of AI-powered prior authorization tools, potentially reducing regulatory uncertainty for payer-facing healthcare AI vendors.

These regulatory updates move in opposite directions: the EU is slowing down while the US is speeding up, which means healthcare AI companies will need to manage different compliance timelines depending on their markets.

Who is the author of this content?

NEW MARKET PITCH TEAM

We track new markets so founders and investors can move faster

We build living “market pitch” documents for emerging markets: from AI to synthetic biology and new proteins. Instead of digging through outdated PDFs, random blog posts, and hallucinated LLM answers, our clients get a clean, visual, always-updated view of what’s really happening. We map the key players, deals, regulations, metrics and signals that matter so you can decide faster whether a market is worth your time. Want to know more? Check out our about page.

How we created this content 🔎📝

At New Market Pitch, we kept seeing the same problem: when you look at a new market, the data is either missing, paywalled, or buried in 300-page reports that feel like they were written in the 80s. On the other side, LLMs and random blog posts give you confident answers with no sources, and sometimes they just make things up. That’s not good enough when you’re about to invest real money or launch a company.

So we decided to fix the experience. For each market we cover, we build a structured database and update it on a regular basis. We track funding rounds, fund memos, M&A moves, partnerships, new products, policy changes, and the real activity of startups and incumbents. Then we turn all of that into a clear “market pitch” that shows where the opportunities are and how people actually win in that space.

Every key data point is checked, sourced, and put back into context by our team. That’s how we can give you both speed and reliability: fast coverage of new markets, without the usual guesswork.